Global Des-?-carboxy Prothrombin (DCP) Biomarker Market 2026 by Company, Regions, Type and Application, Forecast to 2032

January 2026 | 90 pages | ID: G94420D98EE5EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Des-?-carboxy Prothrombin (DCP) Biomarker market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.

Des-gamma-carboxy prothrombin (DCP) is an abnormal form of prothrombin, a clotting factor produced by the liver. This test measures the amount of DCP in the blood to help evaluate whether treatment for one type of liver cancer, hepatocellular carcinoma (HCC), is effective.

This report is a detailed and comprehensive analysis for global Des-?-carboxy Prothrombin (DCP) Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Des-?-carboxy Prothrombin (DCP) Biomarker market size and forecasts, in consumption value ($ Million), 2021-2032

Global Des-?-carboxy Prothrombin (DCP) Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Des-?-carboxy Prothrombin (DCP) Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Des-?-carboxy Prothrombin (DCP) Biomarker market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:
  • To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Des-?-carboxy Prothrombin (DCP) Biomarker
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Des-?-carboxy Prothrombin (DCP) Biomarker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Des-?-carboxy Prothrombin (DCP) Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Hepatocellular Carcinoma
  • Anticoagulant Intoxication
  • Others
Market segment by Application
  • Hospitals
  • Clinics
  • Others
Market segment by players, this report covers
  • FUJIFILM
  • Eli Lilly and Company
  • Fujirebio
  • Roche Diagnostics
  • Fapon Biotech
  • Labcorp
  • Thermo Fisher Scientific
Market segment by regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
  • South America (Brazil, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Des-?-carboxy Prothrombin (DCP) Biomarker product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Des-?-carboxy Prothrombin (DCP) Biomarker, with revenue, gross margin, and global market share of Des-?-carboxy Prothrombin (DCP) Biomarker from 2021 to 2026.

Chapter 3, the Des-?-carboxy Prothrombin (DCP) Biomarker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Des-?-carboxy Prothrombin (DCP) Biomarker market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Des-?-carboxy Prothrombin (DCP) Biomarker.

Chapter 13, to describe Des-?-carboxy Prothrombin (DCP) Biomarker research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Des-?-carboxy Prothrombin (DCP) Biomarker by Type
  1.3.1 Overview: Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type in 2025
  1.3.3 Hepatocellular Carcinoma
  1.3.4 Anticoagulant Intoxication
  1.3.5 Others
1.4 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market by Application
  1.4.1 Overview: Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Application: 2021 Versus 2025 Versus 2032
  1.4.2 Hospitals
  1.4.3 Clinics
  1.4.4 Others
1.5 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Size & Forecast
1.6 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast by Region
  1.6.1 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Region: 2021 VS 2025 VS 2032
  1.6.2 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Region, (2021-2032)
  1.6.3 North America Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
  1.6.4 Europe Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
  1.6.5 Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
  1.6.6 South America Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
  1.6.7 Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 FUJIFILM
  2.1.1 FUJIFILM Details
  2.1.2 FUJIFILM Major Business
  2.1.3 FUJIFILM Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.1.4 FUJIFILM Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 FUJIFILM Recent Developments and Future Plans
2.2 Eli Lilly and Company
  2.2.1 Eli Lilly and Company Details
  2.2.2 Eli Lilly and Company Major Business
  2.2.3 Eli Lilly and Company Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.2.4 Eli Lilly and Company Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Eli Lilly and Company Recent Developments and Future Plans
2.3 Fujirebio
  2.3.1 Fujirebio Details
  2.3.2 Fujirebio Major Business
  2.3.3 Fujirebio Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.3.4 Fujirebio Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Fujirebio Recent Developments and Future Plans
2.4 Roche Diagnostics
  2.4.1 Roche Diagnostics Details
  2.4.2 Roche Diagnostics Major Business
  2.4.3 Roche Diagnostics Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.4.4 Roche Diagnostics Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Roche Diagnostics Recent Developments and Future Plans
2.5 Fapon Biotech
  2.5.1 Fapon Biotech Details
  2.5.2 Fapon Biotech Major Business
  2.5.3 Fapon Biotech Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.5.4 Fapon Biotech Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Fapon Biotech Recent Developments and Future Plans
2.6 Labcorp
  2.6.1 Labcorp Details
  2.6.2 Labcorp Major Business
  2.6.3 Labcorp Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.6.4 Labcorp Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Labcorp Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
  2.7.1 Thermo Fisher Scientific Details
  2.7.2 Thermo Fisher Scientific Major Business
  2.7.3 Thermo Fisher Scientific Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
  2.7.4 Thermo Fisher Scientific Des-?-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Des-?-carboxy Prothrombin (DCP) Biomarker Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Des-?-carboxy Prothrombin (DCP) Biomarker by Company Revenue
  3.2.2 Top 3 Des-?-carboxy Prothrombin (DCP) Biomarker Players Market Share in 2025
  3.2.3 Top 6 Des-?-carboxy Prothrombin (DCP) Biomarker Players Market Share in 2025
3.3 Des-?-carboxy Prothrombin (DCP) Biomarker Market: Overall Company Footprint Analysis
  3.3.1 Des-?-carboxy Prothrombin (DCP) Biomarker Market: Region Footprint
  3.3.2 Des-?-carboxy Prothrombin (DCP) Biomarker Market: Company Product Type Footprint
  3.3.3 Des-?-carboxy Prothrombin (DCP) Biomarker Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value and Market Share by Type (2021-2026)
4.2 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2026)
5.2 Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
6.2 North America Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Application (2021-2032)
6.3 North America Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Country
  6.3.1 North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
  6.3.2 United States Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  6.3.3 Canada Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  6.3.4 Mexico Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
7.2 Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
7.3 Europe Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Country
  7.3.1 Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
  7.3.2 Germany Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  7.3.3 France Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  7.3.5 Russia Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  7.3.6 Italy Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Region
  8.3.1 Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Region (2021-2032)
  8.3.2 China Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  8.3.3 Japan Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  8.3.4 South Korea Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  8.3.5 India Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  8.3.7 Australia Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
9.2 South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
9.3 South America Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Country
  9.3.1 South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
  9.3.2 Brazil Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  9.3.3 Argentina Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Market Size by Country
  10.3.1 Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
  10.3.2 Turkey Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
  10.3.4 UAE Des-?-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Des-?-carboxy Prothrombin (DCP) Biomarker Market Drivers
11.2 Des-?-carboxy Prothrombin (DCP) Biomarker Market Restraints
11.3 Des-?-carboxy Prothrombin (DCP) Biomarker Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Des-?-carboxy Prothrombin (DCP) Biomarker Industry Chain
12.2 Des-?-carboxy Prothrombin (DCP) Biomarker Upstream Analysis
12.3 Des-?-carboxy Prothrombin (DCP) Biomarker Midstream Analysis
12.4 Des-?-carboxy Prothrombin (DCP) Biomarker Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


LIST OF TABLES

Table 1. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Region (2027-2032) & (USD Million)
Table 5. FUJIFILM Company Information, Head Office, and Major Competitors
Table 6. FUJIFILM Major Business
Table 7. FUJIFILM Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 8. FUJIFILM Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. FUJIFILM Recent Developments and Future Plans
Table 10. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 11. Eli Lilly and Company Major Business
Table 12. Eli Lilly and Company Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 13. Eli Lilly and Company Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Eli Lilly and Company Recent Developments and Future Plans
Table 15. Fujirebio Company Information, Head Office, and Major Competitors
Table 16. Fujirebio Major Business
Table 17. Fujirebio Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 18. Fujirebio Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 20. Roche Diagnostics Major Business
Table 21. Roche Diagnostics Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 22. Roche Diagnostics Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Roche Diagnostics Recent Developments and Future Plans
Table 24. Fapon Biotech Company Information, Head Office, and Major Competitors
Table 25. Fapon Biotech Major Business
Table 26. Fapon Biotech Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 27. Fapon Biotech Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Fapon Biotech Recent Developments and Future Plans
Table 29. Labcorp Company Information, Head Office, and Major Competitors
Table 30. Labcorp Major Business
Table 31. Labcorp Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 32. Labcorp Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Labcorp Recent Developments and Future Plans
Table 34. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Scientific Major Business
Table 36. Thermo Fisher Scientific Des-?-carboxy Prothrombin (DCP) Biomarker Product and Solutions
Table 37. Thermo Fisher Scientific Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Thermo Fisher Scientific Recent Developments and Future Plans
Table 39. Global Des-?-carboxy Prothrombin (DCP) Biomarker Revenue (USD Million) by Players (2021-2026)
Table 40. Global Des-?-carboxy Prothrombin (DCP) Biomarker Revenue Share by Players (2021-2026)
Table 41. Breakdown of Des-?-carboxy Prothrombin (DCP) Biomarker by Company Type (Tier 1, Tier 2, and Tier 3)
Table 42. Market Position of Players in Des-?-carboxy Prothrombin (DCP) Biomarker, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 43. Head Office of Key Des-?-carboxy Prothrombin (DCP) Biomarker Players
Table 44. Des-?-carboxy Prothrombin (DCP) Biomarker Market: Company Product Type Footprint
Table 45. Des-?-carboxy Prothrombin (DCP) Biomarker Market: Company Product Application Footprint
Table 46. Des-?-carboxy Prothrombin (DCP) Biomarker New Market Entrants and Barriers to Market Entry
Table 47. Des-?-carboxy Prothrombin (DCP) Biomarker Mergers, Acquisition, Agreements, and Collaborations
Table 48. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (USD Million) by Type (2021-2026)
Table 49. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Share by Type (2021-2026)
Table 50. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Forecast by Type (2027-2032)
Table 51. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2026)
Table 52. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Forecast by Application (2027-2032)
Table 53. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2026) & (USD Million)
Table 54. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2027-2032) & (USD Million)
Table 55. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2026) & (USD Million)
Table 56. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2027-2032) & (USD Million)
Table 57. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2026) & (USD Million)
Table 58. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2026) & (USD Million)
Table 60. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2027-2032) & (USD Million)
Table 61. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2026) & (USD Million)
Table 62. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2027-2032) & (USD Million)
Table 63. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2026) & (USD Million)
Table 64. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2027-2032) & (USD Million)
Table 65. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2026) & (USD Million)
Table 66. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2027-2032) & (USD Million)
Table 67. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2026) & (USD Million)
Table 68. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2027-2032) & (USD Million)
Table 69. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Region (2021-2026) & (USD Million)
Table 70. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Region (2027-2032) & (USD Million)
Table 71. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2026) & (USD Million)
Table 72. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2027-2032) & (USD Million)
Table 73. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2026) & (USD Million)
Table 74. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2027-2032) & (USD Million)
Table 75. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2026) & (USD Million)
Table 76. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2027-2032) & (USD Million)
Table 77. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2026) & (USD Million)
Table 78. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2027-2032) & (USD Million)
Table 79. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2026) & (USD Million)
Table 80. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2027-2032) & (USD Million)
Table 81. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Global Key Players of Des-?-carboxy Prothrombin (DCP) Biomarker Upstream (Raw Materials)
Table 84. Global Des-?-carboxy Prothrombin (DCP) Biomarker Typical Customers

LIST OF FIGURES

Figure 1. Des-?-carboxy Prothrombin (DCP) Biomarker Picture
Figure 2. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type in 2025
Figure 4. Hepatocellular Carcinoma
Figure 5. Anticoagulant Intoxication
Figure 6. Others
Figure 7. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application in 2025
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global Market Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 15. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Region (2021-2032)
Figure 16. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Region in 2025
Figure 17. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 18. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 19. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 20. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 21. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Des-?-carboxy Prothrombin (DCP) Biomarker Revenue Share by Players in 2025
Figure 24. Des-?-carboxy Prothrombin (DCP) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 25. Market Share of Des-?-carboxy Prothrombin (DCP) Biomarker by Player Revenue in 2025
Figure 26. Top 3 Des-?-carboxy Prothrombin (DCP) Biomarker Players Market Share in 2025
Figure 27. Top 6 Des-?-carboxy Prothrombin (DCP) Biomarker Players Market Share in 2025
Figure 28. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Share by Type (2021-2026)
Figure 29. Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Share Forecast by Type (2027-2032)
Figure 30. Global Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Share by Application (2021-2026)
Figure 31. Global Des-?-carboxy Prothrombin (DCP) Biomarker Market Share Forecast by Application (2027-2032)
Figure 32. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type (2021-2032)
Figure 33. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2032)
Figure 34. North America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Country (2021-2032)
Figure 35. United States Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 36. Canada Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 37. Mexico Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 38. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type (2021-2032)
Figure 39. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2032)
Figure 40. Europe Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Country (2021-2032)
Figure 41. Germany Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 42. France Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 43. United Kingdom Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 44. Russia Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 45. Italy Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 46. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type (2021-2032)
Figure 47. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2032)
Figure 48. Asia-Pacific Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Region (2021-2032)
Figure 49. China Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 50. Japan Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 51. South Korea Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 52. India Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 53. Southeast Asia Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 54. Australia Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 55. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type (2021-2032)
Figure 56. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2032)
Figure 57. South America Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Country (2021-2032)
Figure 58. Brazil Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 59. Argentina Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 60. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type (2021-2032)
Figure 61. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2032)
Figure 62. Middle East & Africa Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Country (2021-2032)
Figure 63. Turkey Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 64. Saudi Arabia Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 65. UAE Des-?-carboxy Prothrombin (DCP) Biomarker Consumption Value (2021-2032) & (USD Million)
Figure 66. Des-?-carboxy Prothrombin (DCP) Biomarker Market Drivers
Figure 67. Des-?-carboxy Prothrombin (DCP) Biomarker Market Restraints
Figure 68. Des-?-carboxy Prothrombin (DCP) Biomarker Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Des-?-carboxy Prothrombin (DCP) Biomarker Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source


More Publications